News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Daniel Jones: I had the privilege of attending ASCO GI to present our team’s research
Daniel Jones/LinkedIn
Jan 29, 2025, 14:11

Daniel Jones: I had the privilege of attending ASCO GI to present our team’s research

Daniel Jones,

“I had the privilege of attending ASCO GI to present our team’s research, led by Dr. Kyaw Thein! We were honored to have three meta-analyses accepted for presentation and publication in the Journal of Clinical Oncology.

Here are the links to our research for those interested in exploring them further.”

1. Meta-analysis of randomized controlled trials (RCTs) to evaluate the incidence of hemorrhage and venous thromboembolism (VTE) events in patients with gastrointestinal (GI) cancers treated with fruquintinib.

2. Meta-analysis of phase II/III randomized controlled trials (RCTs) to determine the incidence of hypertension and proteinuria in patients with gastrointestinal (GI) cancers treated with fruquintinib.

3. Meta-analysis of phase II/III randomized controlled trials (RCTs) to evaluate the incidence of hand-foot skin reaction (HFSR) or palmar-plantar erythrodysesthesia (PPE) syndrome in patients with gastrointestinal (GI) cancers treated with fruquintinib.

Daniel Jones: I had the privilege of attending ASCO GI to present our team’s research

ASCO GI 2025 cancer Daniel Jones Journal of Clinical Oncology Kyaw Thein OncoDaily Oncology
Special Coverage
Blog
May 29, 2025, 16:16
From Targeted Therapies to Early Detection, Connect With SCRI at ASCO25 - Sarah Cannon Research Institute
Blog
May 29, 2025, 15:41
Meet The Translational and Therapeutic Research in Pancreatic Cancer Team at Cancer Research Centre of Marseille - AFRCP
Career
May 29, 2025, 15:32
Join University of Arizona Cancer Center at ASCO 2025 to Explore Oncology Job Opportunities
Blog
May 29, 2025, 15:10
FORwards Special Interest Group Webinar on Fear of Cancer Recurrence Featuring Expert Christine Maheu
Blog
May 29, 2025, 14:19
Anna Cabanes on ATOM Coalition's Milestone in Global Cancer Access Program at the Recent Workshop in Zambia
Insight
May 29, 2025, 14:15
New Biomarker May Guide Best Use of KRAS Inhibitors in Lung Cancer
Opinion
May 29, 2025, 13:47
Robin Zon and Andy Guinigundo Highlighted the Importance of Team Attendance at ASCO 2025
Blog
May 29, 2025, 13:35
Habib Nehmé Highlights Elekta’s Record Fourth Quarter and Global Teamwork
Opinion
May 29, 2025, 13:32
List of 10 ADC Presentations Not to Miss at the ASCO 2025 Curated by Paolo Tarantino and Raffaele Colombo
Blog
May 29, 2025, 13:16
Dana Bryson Highlights ACT for Children's Progress in Expanding Pediatric Cancer Access
Insight
May 29, 2025, 13:11
START and OneOncology Partner to Expand Access to Early-Phase Oncology Trials
Blog
May 29, 2025, 13:01
Ruben Mesa: Wonderful panel at CancerX by members of our Advocate Health Cancer National Service Line